المؤلفون: Luo, Jun, Attard, Gerhardt, Balk, Steven, Bevan, Charlotte, Burnstein, Kerry, Cato, Laura, Cherkasov, Artem, De Bono, Johann, Dong, Yan, Gao, Allen, Gleave, Martin, Heemers, Hannelore, Kanayama, Mayuko, Kittler, Ralf, Lang, Joshua, Lee, Richard, Logothetis, Christopher, Matusik, Robert, Plymate, Stephen, Sawyers, Charles, Selth, Luke, Soule, Howard, Tilley, Wayne, Weigel, Nancy, Zoubeidi, Amina, Dehm, Scott, Raj, Ganesh

المصدر: European Urology. 73(5)

مصطلحات موضوعية: Abiraterone, Androgen receptor variant 7, Androgen receptor variants, Castration-resistant prostate cancer, Enzalutamide, Aged, Androgen Antagonists, Androstenes, Benzamides, Biomarkers, Tumor, Congresses as Topic, Disease-Free Survival, Follow-Up Studies, Humans, Male, Middle Aged, Nitriles, Phenylthiohydantoin, Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen, Risk Assessment, Survival Analysis, Treatment Outcome

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/8xm6g3g8Test

المؤلفون: Flaig, Thomas, Plets, Melissa, Hussain, Maha, Agarwal, Neeraj, Mitsiades, Nicholas, Deshpande, Hari, Vaishampayan, Ulka, Thompson, Ian

المصدر: JAMA Oncology. 3(11)

مصطلحات موضوعية: Abiraterone Acetate, Adenocarcinoma, Adult, Aged, Aged, 80 and over, Androgen Antagonists, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols, Disease Progression, Disease-Free Survival, Drug Administration Schedule, Humans, Kallikreins, Male, Middle Aged, Prednisone, Prostate-Specific Antigen, Prostatic Neoplasms, Survival Analysis, Time Factors, Treatment Outcome, United States

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/5qk0q836Test

المؤلفون: Rathkopf, Dana E, Smith, Matthew R, de Bono, Johann S, Logothetis, Christopher J, Shore, Neal D, de Souza, Paul, Fizazi, Karim, Mulders, Peter FA, Mainwaring, Paul, Hainsworth, John D, Beer, Tomasz M, North, Scott, Fradet, Yves, Van Poppel, Hendrik, Carles, Joan, Flaig, Thomas W, Efstathiou, Eleni, Yu, Evan Y, Higano, Celestia S, Taplin, Mary-Ellen, Griffin, Thomas W, Todd, Mary B, Yu, Margaret K, Park, Youn C, Kheoh, Thian, Small, Eric J, Scher, Howard I, Molina, Arturo, Ryan, Charles J, Saad, Fred

المصدر: European Urology. 66(5)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Cancer, Prostate Cancer, Urologic Diseases, Rehabilitation, Aging, Clinical Research, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Abiraterone Acetate, Aged, Androstenes, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols, Cytochrome P-450 Enzyme Inhibitors, Disease Progression, Disease-Free Survival, Double-Blind Method, Drug Administration Schedule, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Metastasis, Neoplasms, Hormone-Dependent, Prednisone, Proportional Hazards Models, Prostatic Neoplasms, Castration-Resistant, Risk Factors, Steroid 17-alpha-Hydroxylase, Time Factors, Treatment Outcome, Abiraterone acetate, Chemotherapy-naive, Efficacy, Metastatic castration-resistant, prostate cancer, Safety, Metastatic castration-resistant prostate cancer, Urology & Nephrology, Clinical sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/61h5828nTest

المؤلفون: Shi Ming Tu, Sumit K. Subudhi, Ana Aparicio, Ioannis Alafis, Brian F. Chapin, Xuemei Wang, Myrto Boukovala, Paul G. Corn, Nicholas Spetsieris, John C. Araujo, Justin A. Weldon, Eleni Efstathiou, Jennifer Wang, Lisa Pruitt, Christopher J. Logothetis, Amado J. Zurita, John Papadopoulos, John J. Davis

المصدر: European Journal of Cancer. 157:259-267

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Abiraterone Acetate, Urology, urologic and male genital diseases, Disease-Free Survival, Drug Administration Schedule, Androgen deprivation therapy, chemistry.chemical_compound, Prostate cancer, Prednisone, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Adverse effect, Aged, Aged, 80 and over, Prostatectomy, business.industry, Hazard ratio, Abiraterone acetate, Prostatic Neoplasms, Androgen Antagonists, Chemoradiotherapy, Adjuvant, Middle Aged, Prostate-Specific Antigen, medicine.disease, Radiation therapy, Oncology, chemistry, Kallikreins, Neoplasm Recurrence, Local, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282c245b98b96574c5edaa7dd1db4db7Test
https://doi.org/10.1016/j.ejca.2021.06.017Test

المؤلفون: David Olmos, Miguel Rodrigo, Carlos Di Capua, Guillermo Velasco, Carlos Ferrer, David Lorente, Rebeca Lozano, Ángel Sánchez-Iglesias, Elena Castro, Nuria Romero-Laorden, Casilda Llácer, Alfredo Sanchez-Hernandez

المساهمون: Instituto de Salud Carlos III, Ministerio de Economía, Industria y Competitividad (España)

المصدر: Repisalud
Instituto de Salud Carlos III (ISCIII)

مصطلحات موضوعية: Male, Quality of life, Oncology, medicine.medical_specialty, Survival, Urology, Population, Disease-Free Survival, nomogram, Prostate cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Post-hoc analysis, Enzalutamide, Humans, Medicine, predictive, Abiraterone, education, education.field_of_study, Framingham Risk Score, business.industry, Proportional hazards model, Hazard ratio, Middle Aged, Nomogram, Prognosis, Metastasic castration-resistant prostate cancer, medicine.disease, Confidence interval, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Hormone Therapy, Androstenes, business, prognostic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276383f3298f8d220156c3f7ca120446Test
https://doi.org/10.1016/j.eururo.2021.07.014Test

المؤلفون: Satoshi Nagamori, Hirotsugu Uemura, Jonathan Siegel, Seigo Kinuya, Atsushi Mizokami, Hiroji Uemura, Hiroaki Kikukawa, Motonobu Nakamura, Nobuaki Matsubara, Makoto Hosono, Yoshiyuki Kakehi, Go Kimura, Heiko Krissel

المصدر: International Journal of Clinical Oncology. 25:720-731

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Prednisolone, Population, Abiraterone Acetate, Bone Neoplasms, Subgroup analysis, Placebo, Gastroenterology, Asymptomatic, Disease-Free Survival, Placebos, Fractures, Bone, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Asian People, Double-Blind Method, Prednisone, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, education, Aged, Aged, 80 and over, education.field_of_study, business.industry, Abiraterone acetate, Hematology, General Medicine, Middle Aged, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, 030104 developmental biology, Oncology, chemistry, 030220 oncology & carcinogenesis, Surgery, medicine.symptom, business, Radium, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817a67b4cb460487fb5d35c653dec61fTest
https://doi.org/10.1007/s10147-019-01589-6Test

المؤلفون: Cindolo, Luca, Natoli, Clara, De Nunzio, Cosimo, De Tursi, Michele, Valeriani, Maurizio, Giacinti, Silvana, Micali, Salvatore, Rizzo, Mino, Bianchi, Giampaolo, Martorana, Eugenio, Scarcia, Marcello, Ludovico, Giuseppe Mario, Bove, Pierluigi, Laudisi, Anastasia, Selvaggio, Oscar, Carrieri, Giuseppe, Bada, Maida, Castellan, Pietro, Boccasile, Stefano, Ditonno, Pasquale, Chiodini, Paolo, Verze, Paolo, Mirone, Vincenzo, Schips, Luigi

المساهمون: Cindolo, Luca, Natoli, Clara, De Nunzio, Cosimo, De Tursi, Michele, Valeriani, Maurizio, Giacinti, Silvana, Micali, Salvatore, Rizzo, Mino, Bianchi, Giampaolo, Martorana, Eugenio, Scarcia, Marcello, Ludovico, Giuseppe Mario, Bove, Pierluigi, Laudisi, Anastasia, Selvaggio, Oscar, Carrieri, Giuseppe, Bada, Maida, Castellan, Pietro, Boccasile, Stefano, Ditonno, Pasquale, Chiodini, Paolo, Verze, Paolo, Mirone, Vincenzo, Schips, Luigi

مصطلحات موضوعية: Abiraterone acetate, Androgen deprivation therapy, Androgen receptor, Castration-resistant prostate cancer, Prostate cancer, Aged, 80 and over, Disease Progression, Disease-Free Survival, Drug-Related Side Effects and Adverse Reaction, Human, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Metastasi, Prostate-Specific Antigen, Prostatectomy, Prostatic Neoplasms, Castration-Resistant, Risk Factor, Treatment Outcome, Oncology, Genetic, Cancer Research

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29126389; info:eu-repo/semantics/altIdentifier/wos/WOS:000415110100011; volume:17; issue:1; firstpage:753; lastpage:754; numberofpages:2; journal:BMC CANCER; http://hdl.handle.net/11380/1166111Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85033493281; http://www.biomedcentral.com/bmccancerTest/

الإتاحة: https://doi.org/10.1186/s12885-017-3755-xTest
http://hdl.handle.net/11380/1166111Test
http://www.biomedcentral.com/bmccancerTest/

المؤلفون: Conteduca, V, Wetterskog, D, Sharabiani, M T A, Grande, E, Fernandez-Perez, M P, Jayaram, A, Salvi, S, Castellano, D, Romanel, A, Lolli, C, Casadio, V, Gurioli, G, Amadori, D, Font, A, Vazquez-Estevez, S, González Del Alba, A, Mellado, B, Fernandez-Calvo, O, Méndez-Vidal, M J, Climent, M A, Duran, I, Gallardo, E, Rodriguez, A, Santander, C, Sáez, M I, Puente, J, Gasi Tandefelt, D, Wingate, A, Dearnaley, D, PREMIERE Collaborators, Spanish Oncology Genitourinary Group, Demichelis, F, De Giorgi, U, Gonzalez-Billalabeitia, E, Attard, G

مصطلحات موضوعية: abiraterone, androgen receptor, biomarker, castration-resistant prostate cancer, enzalutamide, plasma DNA, Adult, Aged, 80 and over, Androstenes, Antineoplastic Agents, Hormonal, Benzamides, Biomarkers, Tumor, Circulating Tumor DNA, DNA Mutational Analysis, Disease Progression, Disease-Free Survival, Europe, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Multiplex Polymerase Chain Reaction, Multivariate Analysis, Mutation, Nitriles, Odds Ratio, Patient Selection

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/11171Test; PMC5834043; http://www.annalsofoncology.org/article/S0923753419322550/pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834043/pdfTest

الإتاحة: https://doi.org/10.1093/annonc/mdx155Test
http://hdl.handle.net/10668/11171Test
http://www.annalsofoncology.org/article/S0923753419322550/pdfTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834043/pdfTest

المؤلفون: Umut Demirci, Irem Bilgetekin, Deniz Gul, Ceyhun Varim, Cemil Bilir, Nadiye Akdeniz, Ilhan Hacibekiroglu, Ayşe Demirci, Berna Oksuzoglu, Sinan Koca, Burcu Gulbagci, Ibrahim Vedat Bayoglu, Havva Yesil Cinkir

المصدر: Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports

مصطلحات موضوعية: Male, Oncology, Abiraterone Acetate, Docetaxel, 030204 cardiovascular system & hematology, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Neoplasm Metastasis, Patient group, Aged, 80 and over, Multidisciplinary, Abiraterone acetate, Middle Aged, Prognosis, Real life data, Progression-Free Survival, Prostatic Neoplasms, Castration-Resistant, Prostate-specific antigen, Treatment Outcome, Outcomes research, 030220 oncology & carcinogenesis, Benzamides, Medicine, Kallikreins, Taxoids, medicine.medical_specialty, Science, Antineoplastic Agents, Castration resistant, Article, Disease-Free Survival, 03 medical and health sciences, Internal medicine, Nitriles, Phenylthiohydantoin, medicine, Humans, Enzalutamide, Progression-free survival, Aged, business.industry, Prostate-Specific Antigen, medicine.disease, chemistry, Hormonal therapies, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90cf7f28915b822269d4caed8d60950fTest
https://doi.org/10.1038/s41598-021-93659-xTest

المؤلفون: Filipa Carneiro, Rui Medeiros, Sara Coelho, Ana Rita Pinto, Ana Rita Lopes, Maria Joaquina Maurício, Ana Sofia Patrão, Jani Silva, Alina Rosinha, Ana Afonso

المصدر: Pharmacogenomics. 21:919-928

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Genotype, Antineoplastic Agents, Disease-Free Survival, Cohort Studies, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, Genetics, medicine, Humans, Enzalutamide, Allele, Genotyping, Aged, Aged, 80 and over, Pharmacology, business.industry, Abiraterone acetate, Middle Aged, medicine.disease, Androgen receptor, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, Receptors, Androgen, Genetic marker, 030220 oncology & carcinogenesis, Disease Progression, Molecular Medicine, Androstenes, Y-Box-Binding Protein 1, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d166e88c305ebab7070d35b69a444721Test
https://doi.org/10.2217/pgs-2020-0008Test